Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19002Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kyzas, P. A. | en |
| dc.contributor.author | Cunha, I. W. | en |
| dc.contributor.author | Ioannidis, J. P. | en |
| dc.date.accessioned | 2015-11-24T18:56:12Z | - |
| dc.date.available | 2015-11-24T18:56:12Z | - |
| dc.identifier.issn | 1078-0432 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19002 | - |
| dc.rights | Default Licence | - |
| dc.subject | Carcinoma, Squamous Cell/metabolism/*pathology | en |
| dc.subject | Head and Neck Neoplasms/metabolism/*pathology | en |
| dc.subject | Humans | en |
| dc.subject | Immunohistochemistry | en |
| dc.subject | Lymphatic Metastasis/diagnosis | en |
| dc.subject | Prognosis | en |
| dc.subject | Vascular Endothelial Growth Factor A/*biosynthesis | en |
| dc.title | Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1158/1078-0432.CCR-04-1870 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/15746043 | - |
| heal.identifier.secondary | http://clincancerres.aacrjournals.org/content/11/4/1434.full.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2005 | - |
| heal.abstract | PURPOSE: Vascular endothelial growth factor (VEGF) is considered as a prime mediator of angiogenesis. Various studies examining the relationship between VEGF protein overexpression with the clinical outcome in patients with head and neck squamous cell carcinoma have yielded inconclusive results. EXPERIMENTAL DESIGN: We conducted a meta-analysis of 12 studies (n = 1.002 patients) that evaluated the correlation between VEGF (detected by immunohistochemistry) and 2-year overall survival. The relation between VEGF and lymph node involvement (11 studies, n = 722) was also examined. Data were synthesized with random effect and fixed effect risk ratios. RESULTS: The estimated risk of death in 2 years was 1.88-fold higher in the VEGF-positive patients [95% confidence interval, 1.43-2.45; P < 0.001 random effect calculations]. Between-study heterogeneity was nonsignificant (P = 0.15) but larger studies tended to provide more conservative estimates (P = 0.097). VEGF overexpression was not significantly associated with the presence of lymph node metastasis (risk ratio, 1.20; 95% confidence interval, 0.97-1.49; P = 0.087) and there was significant between-study heterogeneity (P = 0.08). CONCLUSIONS: Although some modest bias cannot be excluded, VEGF positivity seems to be associated with worse overall survival in patients with head and neck squamous cell carcinoma. | en |
| heal.journalName | Clin Cancer Res | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Kyzas-2005-Prognostic significa.pdf | 154.28 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
